Your browser doesn't support javascript.
loading
Gold Nanoparticles Disrupt the IGFBP2/mTOR/PTEN Axis to Inhibit Ovarian Cancer Growth.
Hossen, Md Nazir; Wang, Lin; Dwivedi, Shailendra Kumar Dhar; Zhang, Yushan; Rao, Geeta; Elechalwar, Chandra Kumar; Sheth, Vinit; Dey, Anindya; Asfa, Sima; Gulla, Suresh Kumar; Xu, Chao; Fung, Kar-Ming; Robertson, J David; Bieniasz, Magdalena; Wilhelm, Stefan; Bhattacharya, Resham; Mukherjee, Priyabrata.
Afiliação
  • Hossen MN; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Wang L; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Dwivedi SKD; Department of Pharmaceutical and Biomedical Sciences, California Northstate College of Pharmacy, Elk Grove, CA, USA.
  • Zhang Y; Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
  • Rao G; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Elechalwar CK; Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Sheth V; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Dey A; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Asfa S; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Gulla SK; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Xu C; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Fung KM; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Robertson JD; Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma, 73019, USA.
  • Bieniasz M; Department of Obstetrics and Gynecology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Wilhelm S; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Bhattacharya R; Department of Pathology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
  • Mukherjee P; Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, 73104, USA.
Adv Sci (Weinh) ; 9(31): e2200491, 2022 11.
Article em En | MEDLINE | ID: mdl-36104215
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Nanopartículas Metálicas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Nanopartículas Metálicas Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos